IoT Medical Devices Market - Global Forecast to 2030
商品番号 : SMB-4233
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 330 |
| 図表数 | 356 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、IoT医療機器市場を分析し、製品、タイプ、接続技術、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、この市場で活動する主要企業の競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。
The global IoT medical devices market is projected to reach USD 154.74 billion by 2030, up from USD 65.08 billion in 2025, reflecting a CAGR of 18.9% during this period. The market is growing rapidly due to an increasing demand for continuous and real-time patient monitoring, particularly with the wider adoption of telehealth. Recent innovations in low-energy sensors, 5G networks, and edge computing have made it possible to efficiently collect and transmit data from wearable and implantable devices to healthcare systems. These advancements enable more proactive and decentralized care, leading to fewer hospital readmissions. Furthermore, the rising incidence of chronic conditions and an aging global population are driving the greater use of these technologies in both home and clinical settings.
世界のIoT医療機器市場は、2025年の650億8000万米ドルから2030年には1,547億4000万米ドルに達し、この期間に年平均成長率（CAGR）18.9%で成長すると予測されています。この市場は、特に遠隔医療の普及に伴い、継続的かつリアルタイムの患者モニタリングに対する需要が高まっていることから、急速に成長しています。低消費電力センサー、5Gネットワーク、エッジコンピューティングにおける近年のイノベーションにより、ウェアラブルデバイスやインプラントデバイスから医療システムにデータを効率的に収集・送信することが可能になりました。これらの進歩により、より積極的かつ分散化されたケアが可能になり、入院再発の減少につながります。さらに、慢性疾患の罹患率の上昇と世界的な人口高齢化により、家庭と医療現場の両方でこれらの技術の利用が拡大しています。
However, the market faces challenges, such as the complexity of integrating with legacy health IT infrastructure, compliance with data privacy regulations like HIPAA and GDPR, and the need to maintain strong cybersecurity to protect patient information in an increasingly connected ecosystem.
しかし、市場は、従来の医療 IT インフラストラクチャとの統合の複雑さ、HIPAA や GDPR などのデータ プライバシー規制への準拠、ますます接続が進むエコシステムで患者情報を保護するための強力なサイバー セキュリティを維持する必要性などの課題に直面しています。
“The hospitals & clinics segment, under the IoT medical devices market, is expected to register the fastest growth during the forecast period.”
In 2024, the hospitals & clinics segment emerged as the leading end user segment in the IoT medical devices market, a position it is expected to maintain in the coming years. This leadership is primarily due to the increasing demand for advanced diagnostic, monitoring, and treatment tools within healthcare facilities. By adopting IoT-enabled technologies, these institutions can enhance patient outcomes through real-time data monitoring, remote care capabilities, and streamlined clinical operations. The ability to continuously track patient vital signs and chronic health conditions allows for quicker interventions and more effective care delivery. Additionally, the integration of IoT with electronic health records (EHRs) and clinical decision-making platforms improves data accuracy and fosters better coordination among care teams. Key factors driving this trend include the push for higher efficiency, rising patient volumes, and the necessity to meet stringent regulatory and quality standards. As a result, hospitals and clinics are making substantial investments in IoT technologies to improve performance, ensure compliance, and provide more responsive, personalized patient care.
“Bluetooth-enabled IoT technology is projected to dominate the IoT medical devices market during the forecast period.”
Bluetooth-enabled IoT technology is rapidly emerging as the fastest-growing connectivity option in the IoT medical devices market. This growth is primarily driven by its energy efficiency, easy integration, and wide compatibility with smartphones, tablets, and wearable healthcare devices. As more healthcare organizations adopt connected solutions for continuous monitoring and patient interaction, Bluetooth has become a reliable and cost-effective method for short-range data exchange. It plays a vital role in devices such as fitness trackers, mobile diagnostic equipment, and home health monitoring tools, where low power consumption and consistent data transfer are crucial.
“Asia Pacific is expected to register fastest market growth during the forecast period.”
The Asia Pacific region is expected to experience the fastest growth in the IoT medical devices market during the forecast period. This growth is primarily driven by the rapid adoption of digital healthcare technologies, including IoT and artificial intelligence. Government initiatives aimed at improving healthcare infrastructure, combined with significant investments in smart hospitals and digital health platforms, are leading to the increased deployment of connected medical devices. Additionally, the rising demand for remote monitoring solutions, fueled by a growing elderly population and an increase in chronic health conditions, is further propelling this trend. Furthermore, enhanced telecommunications networks and supportive regulatory frameworks for digital health services are facilitating the implementation of IoT-based solutions. As a result, Asia-Pacific is emerging as a key player in the global expansion of the IoT medical device industry.
The breakdown of primary participants is as mentioned below:
- By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
- By Region – North America: 32%, Asia Pacific: 32%, Europe: 26%, Latin America: 5% and Middle East & Africa: 5%
Key Players in the IoT Medical Devices Market
The key players functioning in the IoT medical devices market include Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), Boston Scientific Corporation (US), OMRON Corporation (Japan), Baxter International Inc. (US), BIOTRONIK (Germany), Johnson & Johnson Private Limited (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Honeywell International Inc. (US), AliveCor, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Nonin (US), AMD Global Telemedicine (US), iHealth Labs Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), i-SENS, Inc. (Korea), Huntleigh Healthcare Limited (UK), ResMed (US), Masimo (US), Infinium Medical (US), ICU Medical, Inc. (US), and Hamilton Medical (Switzerland).
Research Coverage
The report analyzes the IoT medical devices market and aims to estimate the market size and future growth potential of various market segments based on product, type, connectivity technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will provide valuable insights for both, established companies and new or smaller firms, helping them understand market trends and dynamics. By doing so, they can increase their market share. Companies that purchase this report can employ one or more of the strategies outlined below to enhance their positions in the market.
This report provides insights on:
- Analysis of key drivers: Drivers (government initiatives to promote digital health), restraints (high deployment cost of connected medical devices), opportunities (low doctor-to-patient ratio in several countries), and challenges (data security issues) are key factors influencing the growth of the IoT medical devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the IoT medical devices market
- Market Development: Comprehensive information on the lucrative emerging markets, product, type, connectivity technology, end user, and region
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the IoT medical devices market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, product offerings, and capabilities of the leading players in the IoT medical devices market like Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), and Boston Scientific Corporation (US)
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 INCLUSIONS AND EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 30
1.3.4 CURRENCY CONSIDERED 30
1.4 STAKEHOLDERS 30
1.5 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DESIGN 32
2.1.1 RESEARCH DATA 32
2.1.2 SECONDARY SOURCES 32
2.1.2.1 Key data from secondary sources 33
2.1.3 PRIMARY SOURCES 33
2.1.3.1 Key data from primary sources 34
2.1.3.2 Key industry insights 35
2.2 MARKET SIZE ESTIMATION 36
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
2.4 LIMITATIONS 40
2.5 MARKET SHARE ANALYSIS 40
2.6 ASSUMPTIONS 40
2.7 RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 46
4.1 IOT MEDICAL DEVICES MARKET OVERVIEW 46
4.2 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE AND COUNTRY 47
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN IOT MEDICAL DEVICES MARKET 48
4.4 REGIONAL MIX: IOT MEDICAL DEVICES MARKET 48
4.5 IOT MEDICAL DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 51
5.2.1.1 Government initiatives to promote digital health 51
5.2.1.2 Growing need for cost-containment in healthcare delivery 52
5.2.1.3 Rising focus on patient engagement and patient-centric healthcare 53
5.2.1.4 Evolution of high-speed networking technologies 53
5.2.1.5 Growing focus on patient safety 54
5.2.2 RESTRAINTS 55
5.2.2.1 High deployment costs of connected medical devices 55
5.2.2.2 Lack of skilled IT personnel across healthcare organizations 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Low doctor-to-patient ratio in several countries 56
5.2.4 CHALLENGES 56
5.2.4.1 Data security issues 56
5.2.4.2 Data management and interoperability concerns 60
5.3 INDUSTRY INSIGHTS 60
5.3.1 INCREASING NUMBER OF PRODUCT LAUNCHES 60
5.3.2 GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN HEALTHCARE ECOSYSTEM 61
5.3.3 INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION 62
5.4 TECHNOLOGY ANALYSIS 62
5.5 PORTER’S FIVE FORCES ANALYSIS 63
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 64
5.5.2 BARGAINING POWER OF SUPPLIERS 64
5.5.3 BARGAINING POWER OF BUYERS 64
5.5.4 THREAT OF NEW ENTRANTS 64
5.5.5 THREAT OF SUBSTITUTES 65
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 65
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 65
5.6.2 BUYING CRITERIA 66
5.7 REGULATORY ANALYSIS 66
5.7.1 NORTH AMERICA 66
5.7.1.1 US 66
5.7.1.2 Canada 71
5.7.2 EUROPE 71
5.7.3 ASIA PACIFIC 72
5.7.3.1 Japan 72
5.7.3.2 China 73
5.7.3.3 India 73
5.8 VALUE CHAIN ANALYSIS 74
5.9 ECOSYSTEM ANALYSIS 75
5.10 PRICING ANALYSIS 75
5.11 PATENT ANALYSIS 76
5.11.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 76
5.11.2 LIST OF MAJOR PATENTS 78
5.12 CASE STUDY ANALYSIS 80
5.12.1 CASE STUDY 1: ADVANCING WOUND MEASUREMENT ACCURACY IN HEALTHCARE WITH IOT TECHNOLOGY 80
5.12.2 CASE STUDY 2: EMPOWERING PATIENT-CONTROLLED PAIN MEDICATION ADMINISTRATION WITH IOT TECHNOLOGY 80
5.12.3 CASE STUDY 3: IMPROVING MATERNAL AND FETAL CARE WITH IOT-DRIVEN MONITORING SOLUTIONS 81
5.13 KEY CONFERENCES AND EVENTS, 2025–2026 81
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.15 IMPACT OF 2025 US TARIFFS—IOT MEDICAL DEVICES MARKET 82
5.15.1 INTRODUCTION 82
5.15.2 KEY TARIFF RATES 83
5.15.3 PRICE IMPACT ANALYSIS 84
5.15.4 IMPACT ON COUNTRY/REGION 85
5.15.4.1 US 85
5.15.4.2 Europe 86
5.15.4.3 Asia Pacific 87
5.15.5 IMPACT ON END-USE INDUSTRIES 88
6 IOT MEDICAL DEVICES MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
6.2 VITAL SIGNS MONITORING DEVICES 93
6.2.1 BLOOD GLUCOSE MONITORS 94
6.2.1.1 Preference for continuous glucose monitoring to drive market 94
6.2.2 ECG/HEART RATE MONITORS 95
6.2.2.1 Rising incidence of CVD to drive market growth 95
6.2.3 BLOOD PRESSURE MONITORS 98
6.2.3.1 Growing prevalence of hypertension and obesity to fuel market 98
6.2.4 MULTIPARAMETER MONITORS 100
6.2.4.1 Rising preference for home care to drive demand 100
6.2.5 OXIMETERS 101
6.2.5.1 Increasing focus on self-monitoring to drive market 101
6.3 IMAGING SYSTEMS 102
6.3.1 NEED TO TRANSMIT DATA FOR REMOTE VIEWING TO SUPPORT MARKET GROWTH 102
6.4 IMPLANTABLE CARDIAC DEVICES 104
6.4.1 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS 105
6.4.1.1 Growing geriatric population to boost demand 105
6.4.2 PACEMAKERS 107
6.4.2.1 Rising number of cardiac patients to drive demand 107
6.4.3 IMPLANTABLE CARDIAC MONITORS 108
6.4.3.1 Ease of remote monitoring to drive demand 108
6.5 PATIENT MONITORS 109
6.5.1 GROWING ADOPTION TO BOOST MARKET 109
6.6 RESPIRATORY DEVICES 111
6.6.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE DEMAND 111
6.7 INFUSION PUMPS 112
6.7.1 RISK OF SECURITY BREACHES TO IMPACT MARKET GROWTH 112
6.8 FETAL MONITORING DEVICES 113
6.8.1 GROWING EMPHASIS ON FETAL HEALTH TO DRIVE MARKET GROWTH 113
6.9 NEUROLOGICAL DEVICES 115
6.9.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET 115
6.10 VENTILATORS 117
6.10.1 HIGH DEMAND FOR INTENSIVE CARE TO DRIVE MARKET GROWTH 117
6.11 ANESTHESIA MACHINES 118
6.11.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 118
6.12 HEARING DEVICES 119
6.12.1 RISING ADOPTION OF ADVANCED AIDS TO BOOST MARKET 119
6.13 OTHER IOT MEDICAL DEVICES 120
7 IOT MEDICAL DEVICES MARKET, BY TYPE 122
7.1 INTRODUCTION 123
7.2 STATIONARY DEVICES 123
7.2.1 IMPROVED DATA ACCESSIBILITY TO DRIVE DEMAND 123
7.3 IMPLANTABLE DEVICES 126
7.3.1 INCREASING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES TO DRIVE DEMAND 126
7.4 WEARABLE DEVICES 128
7.4.1 RISING USE IN HOME CARE SETTINGS TO PROPEL MARKET 128
7.5 OTHER DEVICE TYPES 129
8 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY 131
8.1 INTRODUCTION 132
8.2 WI-FI 132
8.2.1 ABILITY TO PROVIDE GREATER FLEXIBILITY TO CAREGIVERS TO SUPPORT MARKET GROWTH 132
8.3 BLUETOOTH 133
8.3.1 SEAMLESS CONNECTION BETWEEN WIRELESS DEVICES TO FOSTER ADOPTION 133
8.4 ZIGBEE 134
8.4.1 SECURITY CONCERNS TO LIMIT ADOPTION 134
8.5 OTHER CONNECTIVITY TECHNOLOGIES 135
9 IOT MEDICAL DEVICES MARKET, BY END USER 136
9.1 INTRODUCTION 137
9.2 HOSPITALS & CLINICS 138
9.2.1 NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET 138
9.3 NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS,
AND HOME CARE SETTINGS 139
9.3.1 INCREASING GERIATRIC POPULATION TO CONTRIBUTE TO SEGMENT GROWTH 139
9.4 OTHER END USERS 140
10 IOT MEDICAL DEVICES MARKET, BY REGION 141
10.1 INTRODUCTION 142
10.2 NORTH AMERICA 143
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143
10.2.2 US 147
10.2.2.1 High adoption of connected devices to drive market 147
10.2.3 CANADA 150
10.2.3.1 Government investments in health-related technologies
to boost market 150
10.3 EUROPE 153
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154
10.3.2 GERMANY 157
10.3.2.1 Government initiatives to boost market 157
10.3.3 UK 160
10.3.3.1 High penetration of wearables to drive market 160
10.3.4 FRANCE 163
10.3.4.1 Government support for e-Health to drive market 163
10.3.5 ITALY 166
10.3.5.1 Widespread use of mobile devices to drive market 166
10.3.6 SPAIN 169
10.3.6.1 Growing geriatric population to propel demand 169
10.3.7 REST OF EUROPE 172
10.4 ASIA PACIFIC 175
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 175
10.4.2 CHINA 179
10.4.2.1 High burden of chronic disorders to drive demand 179
10.4.3 JAPAN 182
10.4.3.1 Demand from large geriatric population to boost market 182
10.4.4 INDIA 185
10.4.4.1 Growing adoption of telemedicine to boost market 185
10.4.5 REST OF ASIA PACIFIC 188
10.5 LATIN AMERICA 192
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 192
10.5.2 BRAZIL 196
10.5.2.1 Increasing government initiatives to drive market 196
10.5.3 MEXICO 199
10.5.3.1 Focus on digitalization of healthcare to support market 199
10.5.4 REST OF LATIN AMERICA 202
10.6 MIDDLE EAST & AFRICA 205
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 206
10.6.2 GCC COUNTRIES 209
10.6.3 REST OF MIDDLE EAST & AFRICA 212
11 COMPETITIVE LANDSCAPE 216
11.1 INTRODUCTION 216
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 216
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET 217
11.3 REVENUE ANALYSIS, 2024 218
11.4 MARKET SHARE ANALYSIS, 2024 218
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221
11.5.1 STARS 221
11.5.2 EMERGING LEADERS 221
11.5.3 PERVASIVE PLAYERS 221
11.5.4 PARTICIPANTS 221
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223
11.5.5.1 Company footprint 223
11.5.5.2 Region footprint 224
11.5.5.3 Product footprint 225
11.5.5.4 Type footprint 226
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 227
11.6.1 PROGRESSIVE COMPANIES 227
11.6.2 RESPONSIVE COMPANIES 227
11.6.3 DYNAMIC COMPANIES 228
11.6.4 STARTING BLOCKS 228
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 229
11.6.5.1 Detailed list of key startups/SMEs 229
11.7 VALUATION & FINANCIAL METRICS 230
11.7.1 FINANCIAL METRICS 230
11.7.2 COMPANY VALUATION 230
11.8 BRAND/SOFTWARE COMPARISON 231
11.9 COMPETITIVE SCENARIO 232
11.9.1 PRODUCT LAUNCHES 232
11.9.2 DEALS 233
11.9.3 EXPANSIONS 233
12 COMPANY PROFILES 234
12.1 KEY COMPANIES 234
12.1.1 MEDTRONIC 234
12.1.1.1 Business overview 234
12.1.1.2 Products offered 235
12.1.1.3 Recent developments 238
12.1.1.3.1 Product launches & approvals 238
12.1.1.3.2 Deals 239
12.1.1.3.3 Other developments 240
12.1.1.4 MnM view 240
12.1.1.4.1 Key strengths/Right to win 240
12.1.1.4.2 Strategic choices 240
12.1.1.4.3 Weaknesses and competitive threats 241
12.1.2 GE HEALTHCARE 242
12.1.2.1 Business overview 242
12.1.2.2 Products offered 243
12.1.2.3 Recent developments 244
12.1.2.3.1 Product launches & approvals 244
12.1.2.3.2 Deals 245
12.1.2.4 MnM view 246
12.1.2.4.1 Key strengths/Right to win 246
12.1.2.4.2 Strategic choices 246
12.1.2.4.3 Weaknesses and competitive threats 246
12.1.3 KONINKLIJKE PHILIPS N.V. 247
12.1.3.1 Business overview 247
12.1.3.2 Products offered 248
12.1.3.3 Recent developments 249
12.1.3.3.1 Product launches & enhancements 249
12.1.3.3.2 Deals 251
12.1.3.3.3 Other developments 252
12.1.3.4 MnM view 252
12.1.3.4.1 Key strengths/Right to win 252
12.1.3.4.2 Strategic choices 253
12.1.3.4.3 Weaknesses and competitive threats 253
12.1.4 ABBOTT 254
12.1.4.1 Business overview 254
12.1.4.2 Products offered 255
12.1.4.3 Recent developments 256
12.1.4.3.1 Product launches & approvals 256
12.1.4.3.2 Deals 258
12.1.4.4 MnM view 259
12.1.4.4.1 Key strengths/Right to win 259
12.1.4.4.2 Strategic choices 259
12.1.4.4.3 Weaknesses and competitive threats 259
12.1.5 BOSTON SCIENTIFIC CORPORATION 260
12.1.5.1 Business overview 260
12.1.5.2 Products offered 262
12.1.5.3 Recent developments 264
12.1.5.3.1 Product launches, enhancements, and approvals 264
12.1.5.3.2 Deals 265
12.1.5.4 MnM view 266
12.1.5.4.1 Key strengths/Right to win 266
12.1.5.4.2 Strategic choices 266
12.1.5.4.3 Weaknesses and competitive threats 266
12.1.6 OMRON CORPORATION 267
12.1.6.1 Business overview 267
12.1.6.2 Products offered 268
12.1.6.3 Recent developments 269
12.1.6.3.1 Product & service launches 269
12.1.6.3.2 Deals 270
12.1.6.3.3 Expansions 270
12.1.7 BAXTER INTERNATIONAL, INC. 271
12.1.7.1 Business overview 271
12.1.7.2 Products offered 272
12.1.7.3 Recent developments 274
12.1.7.3.1 Product launches & approvals 274
12.1.7.3.2 Deals 276
12.1.8 BIOTRONIK 277
12.1.8.1 Business overview 277
12.1.8.2 Products offered 277
12.1.8.3 Recent developments 278
12.1.8.3.1 Product launches & enhancements 278
12.1.8.3.2 Deals 279
12.1.9 JOHNSON & JOHNSON 280
12.1.9.1 Business overview 280
12.1.9.2 Products offered 281
12.1.9.3 Recent developments 282
12.1.9.3.1 Deals 282
12.1.10 NIHON KOHDEN CORPORATION 283
12.1.10.1 Business overview 283
12.1.10.2 Products offered 284
12.1.10.3 Recent developments 285
12.1.10.3.1 Product launches & approvals 285
12.1.10.3.2 Deals 286
12.1.10.3.3 Expansions 286
12.1.11 SIEMENS HEALTHINEERS AG 287
12.1.11.1 Business overview 287
12.1.11.2 Products offered 288
12.1.11.3 Recent developments 288
12.1.11.3.1 Product launches 288
12.1.11.3.2 Deals 289
12.1.12 HONEYWELL INTERNATIONAL, INC. 290
12.1.12.1 Business overview 290
12.1.12.2 Products offered 291
12.1.13 ALIVECOR, INC. 292
12.1.13.1 Business overview 292
12.1.13.2 Products offered 292
12.1.13.3 Recent developments 293
12.1.13.3.1 Product & service launches 293
12.1.13.3.2 Deals 294
12.1.14 DRÄGERWERK AG & CO. KGAA 295
12.1.14.1 Business overview 295
12.1.14.2 Products offered 296
12.1.14.3 Recent developments 296
12.1.14.3.1 Product launches 296
12.1.14.3.2 Deals 297
12.1.15 NONIN 298
12.1.15.1 Business overview 298
12.1.15.2 Products offered 298
12.1.15.3 Recent developments 299
12.1.15.3.1 Product launches 299
12.1.15.3.2 Deals 299
12.1.16 RESMED 300
12.1.16.1 Business overview 300
12.1.16.2 Products offered 302
12.1.16.3 Recent developments 302
12.1.16.3.1 Product launches 302
12.1.16.3.2 Deals 303
12.1.16.3.3 Expansions 304
12.1.16.3.4 Other developments 304
12.1.17 MASIMO 305
12.1.17.1 Business overview 305
12.1.17.2 Products offered 306
12.1.17.3 Recent developments 308
12.1.17.3.1 Product launches & approvals 308
12.1.17.3.2 Deals 309
12.1.18 I-SENS, INC. 310
12.1.18.1 Business overview 310
12.1.18.2 Products offered 311
12.1.18.3 Recent developments 313
12.1.18.3.1 Product launches & approvals 313
12.1.18.3.2 Deals 313
12.1.18.3.3 Expansions 313
12.1.19 ICU MEDICAL, INC. 314
12.1.19.1 Business overview 314
12.1.19.2 Products offered 315
12.1.19.3 Recent developments 316
12.1.19.3.1 Product approvals 316
12.1.19.3.2 Deals 316
12.2 OTHER PLAYERS 317
12.2.1 AMD GLOBAL TELEMEDICINE 317
12.2.2 IHEALTH LABS 317
12.2.3 AEROTEL MEDICAL SYSTEMS 318
12.2.4 HUNTLEIGH HEALTHCARE LIMITED 319
12.2.5 INFINIUM MEDICAL 319
12.2.6 HAMILTON MEDICAL 320
13 APPENDIX 321
13.1 DISCUSSION GUIDE 321
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 326
13.3 CUSTOMIZATION OPTIONS 328
13.4 RELATED REPORTS 328
13.5 AUTHOR DETAILS 329
LIST OF TABLES
TABLE 1 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES ON IOT MEDICAL DEVICES MARKET 51
TABLE 2 MAJOR US HEALTHCARE DATA BREACHES 57
TABLE 3 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 65
TABLE 5 KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES 66
TABLE 6 TESTS AND CERTIFICATION REQUIREMENTS FOR WIRELESSLY
CONNECTED MEDICAL DEVICES 67
TABLE 7 REGULATIONS AND STANDARDS GOVERNING CONNECTED MEDICAL DEVICES 70
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES IN JAPAN 72
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES IN CHINA 73
TABLE 10 AVERAGE COST OF IOT MEDICAL DEVICES, BY PRODUCT 75
TABLE 11 KEY PATENTS IN IOT MEDICAL DEVICES MARKET 78
TABLE 12 IOT MEDICAL DEVICES MARKET: LIST OF CONFERENCES AND EVENTS 81
TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES 83
TABLE 14 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 92
TABLE 15 VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 93
TABLE 16 VITAL SIGNS MONITORING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 93
TABLE 17 BLOOD GLUCOSE MONITORS OFFERED BY KEY MARKET PLAYERS 94
TABLE 18 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 95
TABLE 19 ECG/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 96
TABLE 20 ECG/HEART RATE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 97
TABLE 21 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 98
TABLE 22 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 23 MULTIPARAMETER MONITORS OFFERED BY KEY MARKET PLAYERS 100
TABLE 24 MULTIPARAMETER MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 101
TABLE 25 OXIMETERS OFFERED BY KEY MARKET PLAYERS 101
TABLE 26 OXIMETERS MARKET, BY REGION, 2023–2030 (USD MILLION) 102
TABLE 27 IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 103
TABLE 28 IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 29 IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 30 IMPLANTABLE CARDIAC DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 104
TABLE 31 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OFFERED
BY KEY MARKET PLAYERS 105
TABLE 32 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS MARKET,
BY REGION, 2023–2030 (USD MILLION) 106
TABLE 33 PACEMAKERS OFFERED BY KEY MARKET PLAYERS 107
TABLE 34 PACEMAKERS MARKET, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 35 IMPLANTABLE CARDIAC MONITORS OFFERED BY KEY MARKET PLAYERS 108
TABLE 36 IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 37 PATIENT MONITORS OFFERED BY KEY MARKET PLAYERS 109
TABLE 38 PATIENT MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 111
TABLE 39 RESPIRATORY DEVICES OFFERED BY KEY MARKET PLAYERS 111
TABLE 40 RESPIRATORY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 112
TABLE 41 INFUSION PUMPS OFFERED BY KEY MARKET PLAYERS 113
TABLE 42 INFUSION PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 43 FETAL MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 114
TABLE 44 FETAL MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 45 NEUROLOGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 116
TABLE 46 NEUROLOGICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 47 VENTILATORS OFFERED BY KEY MARKET PLAYERS 117
TABLE 48 VENTILATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 49 ANESTHESIA MACHINES OFFERED BY KEY MARKET PLAYERS 118
TABLE 50 ANESTHESIA MACHINES MARKET, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 51 HEARING DEVICES OFFERED BY KEY MARKET PLAYERS 119
TABLE 52 HEARING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 119
TABLE 53 OTHER IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 120
TABLE 54 OTHER IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 55 IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 123
TABLE 56 STATIONARY IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 124
TABLE 57 STATIONARY IOT MEDICAL DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 125
TABLE 58 IMPLANTABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 126
TABLE 59 IMPLANTABLE IOT MEDICAL DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 127
TABLE 60 WEARABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 128
TABLE 61 WEARABLE IOT MEDICAL DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 129
TABLE 62 OTHER DEVICE TYPES OFFERED BY KEY MARKET PLAYERS 130
TABLE 63 OTHER IOT MEDICAL DEVICE TYPES MARKET, BY REGION,
2023–2030 (USD MILLION) 130
TABLE 64 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 132
TABLE 65 WI-FI-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 66 BLUETOOTH-ENABLED IOT MEDICAL DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 134
TABLE 67 ZIGBEE-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 68 OTHER IOT MEDICAL DEVICE CONNECTIVITY TECHNOLOGIES MARKET,
BY REGION, 2023–2030 (USD MILLION) 135
TABLE 69 IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 137
TABLE 70 IOT MEDICAL DEVICES MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 71 IOT MEDICAL DEVICES MARKET FOR NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 72 IOT MEDICAL DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 73 IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 74 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 75 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 145
TABLE 76 NORTH AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 145
TABLE 77 NORTH AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 78 NORTH AMERICA: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 79 NORTH AMERICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 146
TABLE 80 NORTH AMERICA: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 147
TABLE 81 US: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148
TABLE 82 US: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 83 US: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 84 US: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 85 US: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 149
TABLE 86 US: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 150
TABLE 87 CANADA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 151
TABLE 88 CANADA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 151
TABLE 89 CANADA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 152
TABLE 90 CANADA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 152
TABLE 91 CANADA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 152
TABLE 92 CANADA: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 153
TABLE 93 EUROPE: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 154
TABLE 94 EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 155
TABLE 95 EUROPE: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 96 EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 97 EUROPE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 98 EUROPE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 156
TABLE 99 EUROPE: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 100 GERMANY: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 158
TABLE 101 GERMANY: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 102 GERMANY: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 103 GERMANY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 104 GERMANY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 159
TABLE 105 GERMANY: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 106 UK: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161
TABLE 107 UK: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 108 UK: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 109 UK: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 110 UK: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 162
TABLE 111 UK: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 163
TABLE 112 FRANCE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 164
TABLE 113 FRANCE: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 114 FRANCE: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 115 FRANCE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 116 FRANCE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 165
TABLE 117 FRANCE: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 166
TABLE 118 ITALY: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167
TABLE 119 ITALY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 120 ITALY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 168
TABLE 121 ITALY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 122 ITALY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 168
TABLE 123 ITALY: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 169
TABLE 124 SPAIN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 170
TABLE 125 SPAIN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 126 SPAIN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 171
TABLE 127 SPAIN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 128 SPAIN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 171
TABLE 129 SPAIN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 172
TABLE 130 REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 173
TABLE 131 REST OF EUROPE: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 132 REST OF EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 133 REST OF EUROPE: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 134 REST OF EUROPE: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 174
TABLE 135 REST OF EUROPE: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 175
TABLE 136 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 137 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 177
TABLE 138 ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 139 ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 140 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 141 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 179
TABLE 142 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 179
TABLE 143 CHINA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180
TABLE 144 CHINA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 145 CHINA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 146 CHINA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 147 CHINA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 182
TABLE 148 CHINA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 182
TABLE 149 JAPAN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183
TABLE 150 JAPAN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 151 JAPAN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 152 JAPAN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 153 JAPAN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 185
TABLE 154 JAPAN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 185
TABLE 155 INDIA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186
TABLE 156 INDIA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 157 INDIA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 158 INDIA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 159 INDIA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 188
TABLE 160 INDIA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 188
TABLE 161 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 162 REST OF ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 163 REST OF ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 164 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 165 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 191
TABLE 166 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 192
TABLE 167 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 193
TABLE 168 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 193
TABLE 169 LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 170 LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 171 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 195
TABLE 172 LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 195
TABLE 173 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 196
TABLE 174 BRAZIL: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 197
TABLE 175 BRAZIL: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 176 BRAZIL: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 177 BRAZIL: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 178 BRAZIL: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 198
TABLE 179 BRAZIL: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 199
TABLE 180 MEXICO: IOT MEDICAL DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 200
TABLE 181 MEXICO: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 182 MEXICO: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 183 MEXICO: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 184 MEXICO: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2023–2030 (USD MILLION) 201
TABLE 185 MEXICO: IOT MEDICAL DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 202
TABLE 186 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 203
TABLE 187 REST OF LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 203
TABLE 188 REST OF LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 189 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 190 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 204
TABLE 191 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 205
TABLE 192 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 206
TABLE 193 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 207
TABLE 194 MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 195 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 196 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 197 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 208
TABLE 198 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 209
TABLE 199 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 210
TABLE 200 GCC COUNTRIES: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 210
TABLE 201 GCC COUNTRIES: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 202 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 203 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 211
TABLE 204 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 212
TABLE 205 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 213
TABLE 206 REST OF MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 207 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 208 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 209 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 215
TABLE 210 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET,
BY END USER, 2023–2030 (USD MILLION) 215
TABLE 211 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET, JANUARY 2022–MAY 2025 217
TABLE 212 IOT MEDICAL DEVICES MARKET: DEGREE OF COMPETITION 219
TABLE 213 IOT MEDICAL DEVICES MARKET: REGION FOOTPRINT 224
TABLE 214 IOT MEDICAL DEVICES MARKET: PRODUCT FOOTPRINT 225
TABLE 215 IOT MEDICAL DEVICES MARKET: TYPE FOOTPRINT 226
TABLE 216 IOT MEDICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 229
TABLE 217 IOT MEDICAL DEVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 232
TABLE 218 IOT MEDICAL DEVICES MARKET: DEALS, JANUARY 2022–MAY 2025 233
TABLE 219 IOT MEDICAL DEVICES MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 233
TABLE 220 MEDTRONIC: BUSINESS OVERVIEW 234
TABLE 221 MEDTRONIC: PRODUCTS OFFERED 235
TABLE 222 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 238
TABLE 223 MEDTRONIC: DEALS, JANUARY 2022–MAY 2025 239
TABLE 224 MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2025 240
TABLE 225 GE HEALTHCARE: BUSINESS OVERVIEW 242
TABLE 226 GE HEALTHCARE: PRODUCTS OFFERED 243
TABLE 227 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 244
TABLE 228 GE HEALTHCARE DEALS, JANUARY 2022–MAY 2025 245
TABLE 229 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 247
TABLE 230 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 248
TABLE 231 KONINKLIJKE PHILIPS N.V: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022–MAY 2025 249
TABLE 232 KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2022–MAY 2025 251
TABLE 233 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 252
TABLE 234 ABBOTT: BUSINESS OVERVIEW 254
TABLE 235 ABBOTT: PRODUCTS OFFERED 255
TABLE 236 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 256
TABLE 237 ABBOTT: DEALS, JANUARY 2022–MAY 2025 258
TABLE 238 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 260
TABLE 239 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 262
TABLE 240 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, ENHANCEMENTS,
AND APPROVALS, JANUARY 2022–MAY 2025 264
TABLE 241 BOSTON SCIENTIFIC: DEALS, JANUARY 2022–MAY 2025 265
TABLE 242 OMRON CORPORATION: BUSINESS OVERVIEW 267
TABLE 243 OMRON CORPORATION: PRODUCTS OFFERED 268
TABLE 244 OMRON CORPORATION: PRODUCT & SERVICE LAUNCHES,
JANUARY 2022–MAY 2025 269
TABLE 245 OMRON CORPORATION: DEALS, OMRON CORPORATION 270
TABLE 246 OMRON CORPORATION: EXPANSIONS, OMRON CORPORATION 270
TABLE 247 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW 271
TABLE 248 BAXTER INTERNATIONAL, INC.: PRODUCTS OFFERED 272
TABLE 249 BAXTER INTERNATIONAL, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–MAY 2025 274
TABLE 250 BAXTER: DEALS, JANUARY 2022–MAY 2025 276
TABLE 251 BIOTRONIK: BUSINESS OVERVIEW 277
TABLE 252 BIOTRONIK: PRODUCTS OFFERED 277
TABLE 253 BIOTRONIK PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 278
TABLE 254 BIOTRONIK: DEALS, JANUARY 2022–MAY 2025 279
TABLE 255 JOHNSON & JOHNSON: BUSINESS OVERVIEW 280
TABLE 256 JOHNSON & JOHNSON: PRODUCTS OFFERED 281
TABLE 257 JOHNSON & JOHNSON: DEALS, JANUARY 2022–MAY 2025 282
TABLE 258 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 283
TABLE 259 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 284
TABLE 260 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–MAY 2025 285
TABLE 261 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2022–MAY 2025 286
TABLE 262 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025 286
TABLE 263 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 287
TABLE 264 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 288
TABLE 265 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 288
TABLE 266 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–MAY 2025 289
TABLE 267 HONEYWELL INTERNATIONAL, INC.: BUSINESS OVERVIEW 290
TABLE 268 HONEYWELL INTERNATIONAL, INC.: PRODUCTS OFFERED 291
TABLE 269 ALIVECOR, INC.: BUSINESS OVERVIEW 292
TABLE 270 ALIVECOR, INC.: PRODUCTS OFFERED 292
TABLE 271 ALIVECOR, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025 293
TABLE 272 ALIVECOR, INC.: DEALS, JANUARY 2022–MAY 2025 294
TABLE 273 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 295
TABLE 274 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 296
TABLE 275 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 296
TABLE 276 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2022–MAY 2025 297
TABLE 277 NONIN: BUSINESS OVERVIEW 298
TABLE 278 NONIN: PRODUCTS OFFERED 298
TABLE 279 NONIN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 299
TABLE 280 NONIN: DEALS, JANUARY 2022–MAY 2025 299
TABLE 281 RESMED: COMPANY OVERVIEW 300
TABLE 282 RESMED: PRODUCTS OFFERED 302
TABLE 283 RESMED: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 302
TABLE 284 RESMED: DEALS, JANUARY 2022–MAY 2025 303
TABLE 285 RESMED: EXPANSIONS, JANUARY 2022–MAY 2025 304
TABLE 286 RESMED: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 304
TABLE 287 MASIMO: COMPANY OVERVIEW 305
TABLE 288 MASIMO: PRODUCTS OFFERED 306
TABLE 289 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 308
TABLE 290 MASIMO: DEALS, JANUARY 2022–MAY 2025 309
TABLE 291 I-SENS, INC.: COMPANY OVERVIEW 310
TABLE 292 I-SENS, INC.: PRODUCTS OFFERED 311
TABLE 293 I-SENS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 313
TABLE 294 I-SENS, INC.: DEALS, JANUARY 2022–MAY 2025 313
TABLE 295 I-SENS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025 313
TABLE 296 ICU MEDICAL, INC.: COMPANY OVERVIEW 314
TABLE 297 ICU MEDICAL, INC.: PRODUCTS OFFERED 315
TABLE 298 ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 316
TABLE 299 ICU MEDICAL, INC.: DEALS, JANUARY 2022–MAY 2025 316
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 32
FIGURE 2 PRIMARY SOURCES 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS DEMAND SIDE AND SUPPLY SIDE:
BY COMPANY TYPE, DESIGNATION, AND REGION 35
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 38
FIGURE 7 BOTTOM-UP APPROACH 38
FIGURE 8 TOP-DOWN APPROACH 39
FIGURE 9 DATA TRIANGULATION METHODOLOGY 39
FIGURE 10 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2025 VS. 2030(USD MILLION) 42
FIGURE 11 IOT MEDICAL DEVICES MARKET, BY TYPE, 2025 VS. 2030(USD MILLION) 43
FIGURE 12 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 43
FIGURE 13 IOT MEDICAL DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF IOT MEDICAL DEVICES MARKET 45
FIGURE 15 RISING GLOBAL DEMAND FOR REMOTE PATIENT MONITORING
TO DRIVE MARKET GROWTH 46
FIGURE 16 STATIONARY MEDICAL DEVICES TO COMMAND LARGEST SHARE OF
ASIA PACIFIC MARKET IN 2024 47
FIGURE 17 CHINA TO RECORD HIGHEST CAGR IN GLOBAL MARKET 48
FIGURE 18 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 49
FIGURE 20 IOT MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 50
FIGURE 21 HEALTHCARE SPENDING, BY COUNTRY, 2023 (% OF GDP) 52
FIGURE 22 NUMBER OF SMARTPHONE USERS, BY COUNTRY, 2022 54
FIGURE 23 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 65
FIGURE 25 KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES 66
FIGURE 26 VALUE CHAIN ANALYSIS, 2024 74
FIGURE 27 IOT MEDICAL DEVICES MARKET: ECOSYSTEM 75
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015–MAY 2025) 76
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF IOT MEDICAL DEVICES (JANUARY 2015–MAY 2025) 77
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR IOT MEDICAL DEVICE PATENTS (JANUARY 2015–MAY 2025) 78
FIGURE 31 IOT MEDICAL DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMERS’ BUSINESSES 82
FIGURE 32 NORTH AMERICA: IOT MEDICAL DEVICES MARKET SNAPSHOT 144
FIGURE 33 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET SNAPSHOT 176
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2024 218
FIGURE 35 IOT MEDICAL DEVICES MARKET: MARKET SHARE ANALYSIS, 2024 219
FIGURE 36 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 222
FIGURE 37 IOT MEDICAL DEVICES MARKET: COMPANY FOOTPRINT 223
FIGURE 38 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 228
FIGURE 39 EV/EBITDA OF KEY VENDORS 230
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 230
FIGURE 41 IOT MEDICAL DEVICES MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023) 235
FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 243
FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 247
FIGURE 45 ABBOTT: COMPANY SNAPSHOT (2024) 255
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 261
FIGURE 47 OMRON CORPORATION: COMPANY SNAPSHOT (2024) 267
FIGURE 48 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 272
FIGURE 49 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 281
FIGURE 50 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024) 284
FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 287
FIGURE 52 HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 291
FIGURE 53 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024) 295
FIGURE 54 RESMED: COMPANY SNAPSHOT (2024) 301
FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024) 306
FIGURE 56 I-SENS, INC.: COMPANY SNAPSHOT (2024) 311
FIGURE 57 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 315
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 軟組織修復市場 – 2030年までの世界予測 2025-07-02
- エポキシ樹脂市場 – 2030年までの世界予測 2025-07-02
- スマートガスメーター市場 – 2030年までの世界予測 2025-07-02
- サイバーセキュリティ市場 – 2030年までの世界予測 2025-07-02
- パイプ用断熱材市場 – 2030年までの世界予測 2025-07-01